Federated Hermes
NXTM

Federated Hermes’s NxStage Medical Inc. NXTM Stock Holding History

Federated Hermes’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,038
Closed -$29K – 2377
2018
Q2 		$29K Buy
1,038
+138
+15% +$3.7K ﹤0.01% 1758
2018
Q1 		$22K Buy
900
+47
+6% +$1.14K ﹤0.01% 1757
2017
Q4 		$21K Sell
853
-23
-3% -$606 ﹤0.01% 1766
2017
Q3 		$24K Sell
876
-56
-6% -$1.49K ﹤0.01% 1728
2017
Q2 		$23K Buy
932
+57
+7% +$1.41K ﹤0.01% 1744
2017
Q1 		$23K Sell
875
-121
-12% -$3.34K ﹤0.01% 1733
2016
Q4 		$26K Sell
996
-70
-7% -$1.73K ﹤0.01% 1735
2016
Q3 		$27K Sell
1,066
-108
-9% -$2.52K ﹤0.01% 1724
2016
Q2 		$25K Sell
1,174
-11,105
-90% -$198K ﹤0.01% 1731
2016
Q1 		$184K Buy
+12,279
New +$206K ﹤0.01% 1495

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Federated Hermes's NXTM Position: Q3 2018 in Review

Federated Hermes sold out of NxStage Medical Inc. (NXTM) in Q3 2018, closing a stake of 1,038 shares — an estimated $29K sold.

Federated Hermes first reported a position in NXTM in Q1 2016 and held it in 10 quarters. The position peaked at $184K in Q1 2016. 175 funds tracked by Wall St. Rank hold NXTM as of Q3 2018.

  • Federated Hermes reported no remaining NxStage Medical Inc. position as of Q3 2018 after selling out during the quarter.
  • Federated Hermes sold 1,038 NxStage Medical Inc. shares in Q3 2018, an estimated $29K.
  • Federated Hermes first reported a position in NxStage Medical Inc. in Q1 2016 and held it in 10 quarters.
  • Federated Hermes's NxStage Medical Inc. position peaked at $184K in Q1 2016.
  • 175 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2018.

Based on Federated Hermes's 13F filing for Q3 2018, filed 13 Nov 2018.